13 telehealth listings + LillyDirect comparedChecked August 14, 2026Scores set by methodology, not paymentMethodology
Foundayo (Orforglipron)

Foundayo (orforglipron): price and where to get it online (2026)

Where to actually get it

Featured affiliate partners; we may earn a commission, which never changes a score. Full spread in the table below.

Not sure this is your medication? 60-second match quiz →

Verified September 3, 2026: Foundayo (orforglipron) is Eli Lilly's FDA-approved once-daily oral GLP-1 pill, approved April 1, 2026. LillyDirect self-pay is dose-dependent: $149/mo at 0.8 mg; $199/mo at 2.5 mg; $299/mo at 5.5 mg or 9 mg; $299/mo at 14.5 mg or 17.2 mg when refilled within 45 days, otherwise $349/mo. We compare 13 telehealth sources plus LillyDirect below; provider program prices may include different services and are not necessarily the medication total.

Independently researched. Every statistic links to a primary source, see our editorial policy. Affiliate status never changes a provider's score (featured picks are disclosed). Last verified September 2026.
Apr 1, 2026
FDA Approval Date
~$149/mo
Cash Starter Price
12.4%
Weight Loss (ATTAIN-1)
13+1
Sources Compared

What is Foundayo (orforglipron)?

Foundayo is the brand name. Orforglipron is the generic drug name. They are the same medicine.

Foundayo is Eli Lilly's once-daily oral GLP-1 receptor agonist. Unlike Ozempic, Wegovy, or Zepbound, it is a non-peptide small molecule. That structure survives stomach acid, so it works as a pill with no injection and no meal-timing fast.

The FDA approved Foundayo on April 1, 2026 for chronic weight management in adults with BMI ≥30, or BMI ≥27 with a weight-related condition. Commercial launch followed April 6, 2026.

In the ATTAIN-1 Phase 3 trial (N=1,401, 72 weeks, NEJM), Foundayo produced 12.4% mean body weight loss versus 2.3% for placebo. It is the first FDA-approved non-peptide oral GLP-1 for weight loss.

The UK authorised orforglipron on August 10, 2026, and for two indications, not one. The MHRA's own announcement is titled "UK first in Europe to authorise orforglipron for weight management and type 2 diabetes." Most coverage that reached US readers four to six days later framed it as Europe's first weight-loss pill approval and dropped the diabetes half. Two corrections worth carrying: this is a UK authorisation and not an EU one, so it says nothing about EMA timing; and it does not change what Foundayo is approved for in the United States, where the FDA indication remains chronic weight management only. A UK licence is not a US one, and asking a US prescriber for Foundayo to treat type 2 diabetes is an off-label request here regardless of what the MHRA authorised.

Highest Methodology Score Among Current Foundayo Listings
Sesame Care, program from $99/mo

7.9/10 score. Users who want cheap FDA-approved brand-name GLP-1 access ($149-349/mo Wegovy and Zepbound via Success by Sesame), or insured patients who just need a prescriber

Read our full Sesame Care review →
Visit Sesame Care

Where can I get Foundayo online?

These telehealth sources carry Foundayo (orforglipron), sorted by their program starting price. LillyDirect's medication ladder is $149/mo at 0.8 mg; $199/mo at 2.5 mg; $299/mo at 5.5 mg or 9 mg; $299/mo at 14.5 mg or 17.2 mg when refilled within 45 days, otherwise $349/mo. Provider totals can differ because of membership or consultation fees and insurance handling.

“Program from” is each provider's starting monthly price from our data file, not necessarily the Foundayo-specific price. Confirm the exact Foundayo cost on the provider's site.

#SourceProgram FromScoreTypeInsurance
1WeightWatchers (Sequence)
#21 overall
$74/mo membership + medication
membership only; $25/mo for the first two months on the 12-month plan, then $74/mo, on its pricing page (verified 2026-09-03); the plan auto-renews for another 12 months and GLP-1 medication is billed separately
7.4/10BrandYesRead review
2Maximus
#48 overall
published $79.99/mo; total not verified
published microdose medication price; consultation and lab fees are separate, total not verified; standard dosing reaches $299.99/mo
5.1/10BothNoRead review
3Sesame Care
#5 overall
published $99/mo; total not verified
published month-to-month program fee; medication is separate, medication-inclusive total not verified
7.9/10BrandYesCheck Price
4SkinnyRx
#46 overall
$99 first month, rises after
$99 is a first month rate quoted on the compounded semaglutide and tirzepatide injection product pages. SkinnyRx does not publish a month two price; its terms say the renewal rate is described during checkout.
5.3/10BothNoRead review
5GoodRx Care
#39 overall
$119/mo subscription + medication
GoodRx Care subscription only; medication is billed separately
6.2/10BrandYesRead review
6Mochi Health
#13 overall
from $139/mo7.7/10BothNoRead review
7Found
#27 overall
published $148/mo; total not verified
derived: $49/mo membership + compounded GLP-1 from $99/mo with flat pricing across doses; clinician visits are billed separately (most members pay under $30/visit), so the total is not verified. Insured path floors near $99/mo ($50 copay + membership)
7.3/10BothYesCheck Price
8Ro
#33 overall
$149/mo membership + medication7.2/10BrandYesCheck Price
9Ivim Health
#6 overall
from $150/mo
membership $75 + $75/mo semaglutide on the 12-month package
7.9/10BothYesRead review
10Shed
#11 overall
from $159/mo
the $159 floor is the 12-month semaglutide plan on the pricing page; 6-month is $179 and month to month is $199, verified 2026-09-03
7.8/10BothNoRead review
11Hims
#40 overall
$188 first month, then $298/mo
all-in floor for a $149 medication: $188 first month ($39 required Weight Loss Membership + $149 medication), then $298/mo ($149 membership + $149 medication); exact product and dose price varies
5.9/10BrandNoRead review
12Hers
#44 overall
$188 first month, then $298/mo
all-in floor for a $149 medication: $188 first month ($39 required Weight Loss Membership + $149 medication), then $298/mo ($149 membership + $149 medication); exact product and dose price varies
5.3/10BothNoCheck Price
13Calibrate
#14 overall
published $199/mo; total not verified
program fee only; medication billed separately, all-in total not verified
7.7/10BrandYesRead review

Buy Foundayo direct from Eli Lilly (LillyDirect)

You can also order Foundayo through the manufacturer channel. LillyDirect self-pay is $149/mo at 0.8 mg; $199/mo at 2.5 mg; $299/mo at 5.5 mg or 9 mg; $299/mo at 14.5 mg or 17.2 mg when refilled within 45 days, otherwise $349/mo. The approved tablet sequence is 0.8 → 2.5 → 5.5 → 9 → 14.5 → 17.2 mg, with at least 30 days at each strength before any prescriber-directed increase. Foundayo is also dispensed through Amazon Pharmacy and GoodRx.

Visit LillyDirect →

LillyDirect is the manufacturer's own pharmacy. This is an informational link, not an affiliate placement.

Foundayo vs the Wegovy pill vs compounded oral GLP-1

Three ways to take a GLP-1 by mouth in 2026. Only two are FDA-approved for weight loss.

FactorFoundayo (orforglipron)Wegovy pill (semaglutide 25mg)Compounded oral semaglutide
FDA-approved for weight lossYes (Apr 1, 2026)Yes (Dec 2025)No (not FDA-approved)
Phase 3 weight loss12.4% at 72 wks (ATTAIN-1)16.6% at 68 wks (OASIS)No trial data
Fasting requiredNoYes (30-min pre-dose fast)Varies by formulation
Lowest self-pay cost~$149/mo (LillyDirect starter)From $149/mo cash, dose-dependent; $1,349/mo list~$199/mo
StructureNon-peptide small moleculePeptide (semaglutide)Peptide (pharmacy-mixed)

These percentages come from separate trials with different populations, designs, doses and follow-up periods: oral Wegovy reported 16.6% in OASIS, injectable semaglutide 14.9% in STEP-1 (NEJM), and tirzepatide 20.9% in SURMOUNT-1 (NEJM). They do not establish a class-wide oral-versus-injectable ranking or predict an individual result.

Compounded note: compounded oral semaglutide is not FDA-approved and has no dedicated trial data; bioavailability and quality vary by pharmacy. With two FDA-approved oral pills now available, the case for compounded oral semaglutide is weaker than it was in 2024-2025.

A lower oral semaglutide dose is being tested, and the data is years out. Novo Nordisk started a Phase 3 dose-selection study, OASIS 5 (NCT07770841), on August 12, 2026. It tests two lower once-daily oral semaglutide doses against placebo in 450 participants across 62 sites, quadruple-masked, with percent body-weight change at week 60 as the primary endpoint. Primary completion is estimated for February 22, 2028.

What that means if you are shopping now, which is our read and not the registry's: the only oral semaglutide strength you can buy today is 25 mg. The registry does not mention price, tiers or commercial plans, so treat any claim that this trial creates a cheaper Wegovy tablet as speculation. Data that could support a lower strength is not expected before 2028 at the earliest, and a filing and a launch would each add time after that. If what you want is a lower-dose oral GLP-1 that exists right now, that is Foundayo at 0.8 mg for $149 a month, in the first column of the table above.

How much does Foundayo cost with insurance?

Foundayo's list price (WAC) is about $649/month. Most people pay far less.

With commercial insurance + Lilly's savings card: ~$25/month (the same copay structure as Zepbound). CVS Caremark added Foundayo to its standard commercial formulary effective June 1, 2026.

With Medicare: $50/month flat. As of July 1, 2026, Medicare Part D covers Foundayo at a $50 copay through the GLP-1 Bridge demonstration. See our Medicare GLP-1 Bridge guide for eligibility and how to enroll.

Paying cash through LillyDirect: $149/mo at 0.8 mg; $199/mo at 2.5 mg; $299/mo at 5.5 mg or 9 mg; $299/mo at 14.5 mg or 17.2 mg when refilled within 45 days, otherwise $349/mo. A prescription is required; confirm the strength and refill deadline before checkout.

Foundayo side effects (quick summary)

What are Foundayo's side effects?

Foundayo's most common side effects are gastrointestinal and mirror other GLP-1 drugs: nausea, diarrhea, constipation, and vomiting. In ATTAIN-1, symptoms were most frequent during dose escalation and eased at steady state.

This page is a pricing and access overview, not medical guidance. For dose-by-dose management protocols and red flags, read our full breakdown.

Foundayo side effects: full guide →

Frequently Asked Questions

What is Foundayo?+
Foundayo is the brand name for orforglipron, Eli Lilly's FDA-approved once-daily oral GLP-1 receptor agonist for chronic weight management. It was approved April 1, 2026. It is the first non-peptide small-molecule oral GLP-1 for weight loss, so it works as a pill with no injection and no fasting requirement.
Is Foundayo the same as orforglipron?+
Yes. Foundayo is the brand name and orforglipron is the generic drug name. They are the same medicine from Eli Lilly.
How much does Foundayo cost?+
LillyDirect self-pay is $149/mo at 0.8 mg; $199/mo at 2.5 mg; $299/mo at 5.5 mg or 9 mg; $299/mo at 14.5 mg or 17.2 mg when refilled within 45 days, otherwise $349/mo. A prescription is required. Eligible commercially insured patients may pay about $25/month with Lilly's savings card. Eligible Medicare Part D patients pay a $50/month copay through the GLP-1 Bridge program.
Where can I get Foundayo online?+
Foundayo is available directly from LillyDirect (the manufacturer's pharmacy), plus Amazon Pharmacy and GoodRx. Several telehealth platforms also list it. We compare 13 telehealth listings on this page, sorted by program price; a listing is not a safety or compliance certification.
Foundayo vs the Wegovy pill: which is better?+
The Wegovy pill produced 16.6% weight loss in OASIS, while Foundayo produced 12.4% in ATTAIN-1; these were separate trials, not a head-to-head comparison. NovoCare lists the Wegovy pill from $149/month, while Foundayo starts at $149/month and follows a dose/refill-dependent ladder. Foundayo has no fasting requirement; the Wegovy pill requires a 30-minute pre-dose fast. A prescriber should weigh indication, contraindications, coverage, and dosing routine.
Does Medicare cover Foundayo in 2026?+
Yes. As of July 1, 2026, Medicare Part D covers Foundayo at a $50/month flat copay through the GLP-1 Bridge demonstration, which runs through December 31, 2027. Prior authorization applies.

Next step: read our full Sesame Care review (the highest-scoring current Foundayo listing that meets the dated-tier eligibility above), or take the 2-minute match quiz to find the right GLP-1 program for you.

Medical disclaimer: This page compares telehealth pricing and access for Foundayo (orforglipron) and is for informational purposes only. It does not constitute medical advice and makes no guarantee of weight-loss outcomes. Foundayo is a prescription medication, consult a licensed healthcare provider to determine if it is appropriate for you.
Featured Partners

Four affiliate partners we feature, we may earn a commission.

Embody

7.3/10
from $69/mo·Compounded

Gala

7.2/10
from $149/mo·Brand & Compounded

Ro

7.2/10
$149/mo membership + medication·Brand

Fridays

8.7/10
from $117/mo·Brand & Compounded

Affiliate links, we earn a commission at no extra cost to you. These are featured partners, prioritized by our affiliate economics, not an editorial "best" ranking. The objective ranking (by methodology score) and full methodology are at glp1picks.com/best.